Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. by Morais-Almeida, M et al.
ORIGINAL ARTICLE EP IDEMIOLOGY AND GENETICS
Prevalence and classification of rhinitis in preschool
children in Portugal: a nationwide study
M. Morais-Almeida1,2, N. Santos1,3, A. M. Pereira1,3,4, M. Branco-Ferreira2,5, C. Nunes2,6,
J. Bousquet7 & J. A. Fonseca2,3,4,8,9
1Immunoallergy Department, Hospital CUF-Descobertas, Lisbon; 2Sociedade Portuguesa de Alergologia e Imunologia Clınica (SPAIC), Lisbon;
3Allergy and Clinical Immunology Department, Centro Hospitalar S. Jo~ao EPE, Porto; 4Health Information and Decision Sciences
Department, Faculdade de Medicina da Universidade do Porto, Porto; 5Centro Hospitalar Lisboa Norte, Immunoallergy Department, Lisboa;
6Centro de Imunoalergologia do Algarve, Portim~ao, Portugal; 7Department of Allergy and Respiratory Diseases, University Hospital and
INSERM, Montpellier, France; 8Allergy Unit, Hospital-CUF Porto and Instituto CUF-Diagnostico e Tratamento Porto; 9CINTESIS – Center for
Research in Health Technologies and Information Systems, Porto, Portugal
To cite this article: Morais-Almeida M, Santos N, Pereira AM, Branco-Ferreira M, Nunes C, Bousquet J, Fonseca JA. Prevalence and classification of rhinitis in
preschool children in Portugal: a nationwide study. Allergy 2013; 68: 1278–1288.
Keywords
classification; epidemiology; preschool
children; rhinitis; severity.
Correspondence
Mario Morais-Almeida, Department of
Immunoallergy, Hospital CUF-Descobertas,
Rua Mario Botas–Parque das Nac~oes,
1998-018 Lisbon, Portugal.
Tel.: +351-917232267
Fax: +351-210025220
E-mail: mmoraisalmeida@netcabo.pt
Accepted for publication 12 June 2013
DOI:10.1111/all.12221
Edited by: Wytske Fokkens
Abstract
Background: Information on rhinitis epidemiology in preschool children is scarce.
Objectives: To estimate, in children with 3–5 years of age, current rhinitis preva-
lence, to describe rhinitis symptoms and associated sociodemographic characteris-
tics, and to report allergic rhinitis and its impact on asthma (ARIA) classification.
Methods: Cross-sectional, nationwide, population-based study including children
aged 3–5 years. A multistep selection strategy was used to obtain a representative
sample. Data were collected at kindergartens and parish centers by face-to-face
interview to caregivers, using an adapted ISAAC questionnaire. ‘Current rhinitis’
(CR) was defined as the presence of ≥1 rhinitis symptom (repeated sneezing and/
or itchy nose, blocked nose for >1 h, or runny nose without having a cold/flu) in
the last year. Rhinitis lasting ≥4 days/week and ≥4 consecutive weeks was classi-
fied as persistent. Moderate–severe disease interfered ‘a moderate amount’ or ‘a
lot’ in daily activities.
Results: Five thousand and eighteen children were included. CR prevalence was
43.4% [95% CI (42.0–44.8%); n = 2179] and that of physician-diagnosed rhinitis
was 11.7% [95% CI (10.8–12.6%); n = 588]. Of children with CR, 67% reported
blocked nose, 48% rhinorrhea, and 46% sneezing/itchy nose. Considering ARIA
classification, 30% of the population had mild intermittent, 3% mild persistent,
7% moderate–severe intermittent, and 3% moderate–severe persistent rhinitis.
Children with CR had more current wheezing, physician-diagnosed asthma, self-
reported food allergy, and family history of allergic disease. These characteristics
were also associated with persistent and moderate–severe rhinitis.
Conclusions: This is the first nationwide population-based study reporting rhinitis
prevalence and ARIA classification in preschool children. In this age-group, rhini-
tis is frequent and underdiagnosed. About 25% children with rhinitis presented
moderate–severe disease.
Abbreviations
ARIA, allergic rhinitis and its impact on asthma; ETS, environmental tobacco smoke; ISAAC, International Study of Asthma and Allergies in
Childhood; NUTS II, Nomenclature of Territorial Units for Statistics, second level; OECD, Organization for Economic
Co-operation and Development.
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Allergic rhinitis is the most prevalent chronic disease in
affluent countries, with a prevalence of up to 40% in school-
aged children and 30% in adults (1–4). In preschool children,
however, epidemiological data on rhinitis prevalence are
scarce (5–7).
Allergic rhinitis and its impact on asthma (ARIA)
recently recommended that studies should be performed in
preschoolers to better understand the disease prevalence and
phenotypes (8). However, in epidemiological studies, the
definition of ‘rhinitis’, especially in young children, is chal-
lenging. Previous studies (5) have shown that ‘rhinitis’ is
frequently underdiagnosed in this age-group, which hampers
the use of self-reported physician-diagnosed rhinitis as the
most appropriate ‘rhinitis’ definition. In the past 2 decades,
the most widely used definitions were based on the ques-
tionnaire items from the validated International Study of
Asthma and Allergies in Childhood (ISAAC) (9). ISAAC
questions were considered appropriate to define ‘rhinitis’
(10).
The ARIA classification, which ranks rhinitis according to
its duration and severity, has been developed for use in allergic
rhinitis (4). In adults, the ARIA classification has already been
used to classify rhinitis irrespective of the atopy status (11).
To our knowledge, there is no population-based, nation-
wide study reporting the prevalence of rhinitis or the ARIA
classification of rhinitis in preschool children. The aims of
this study were to assess (i) the prevalence of rhinitis in pre-
school children (3–5 years) based on the ISAAC question-
naire (9), (ii) individual rhinitis symptoms, (iii) the ARIA
classification, and (iv) sociodemographic characteristics asso-
ciated with rhinitis in this age-group.
Methods
Study design
This study was a cross-sectional, nationwide, descriptive
study in Portuguese children between 3 and 5 years of age. A
questionnaire was applied by interviewers to characterize rhi-
nitis, its severity and common risk factors or comorbidities.
This study was conducted according to the principles of
the Helsinki Declaration. Verbal informed consent was
obtained from the caretakers of all participating children.
This procedure was approved by the Ethics Committee of the
Hospital CUF-Descobertas, Lisbon, Portugal.
Setting
This study was held in mainland Portugal, which is divided
into five regions (second level of the Nomenclature of Terri-
torial Units for Statistics – NUTS II) and 278 municipalities.
The 2001 Census of the Portuguese Population (12) reported
the existence of 296434 children with 3–5 years of age in
mainland Portugal. The Organization for Economic Co-oper-
ation and Development (OECD) (13) stated that in 2005,
more than 80% of the Portuguese children with 4 years of
age and more than 60% of those with 3 years attended
kindergartens.
Sample size
Based on published data (3), we expected a prevalence of rhi-
nitis in preschool children of 20%. To classify rhinitis
according to ARIA, and considering that only around 10%
of children would have more severe and persistent forms of
rhinitis, with a margin of error of 1.9% and a confidence
interval of 95%, we would need to evaluate at least 1000
individuals with current rhinitis. With a margin of error of
1% and with a confidence interval of 95%, we would need
5000 participants to be able to characterize the prespecified
number of children. To account for refusal, 500 additional
individuals would need to be contacted.
Participants
Portuguese children, with 3–5 years of age, were eligible to
participate. A multistep selection strategy was used to
obtain a representative sample of the target population.
First, the number of participants needed from each Portu-
guese region was defined based on the data from the 2001
Census on 3- to 5-year-old children (12). Second, Portu-
guese municipalities were randomly selected until reaching a
prespecified number of children, considering that each
municipality would provide between 50 and 70 individuals
(Table S1 and Figure S1). Finally, kindergartens and parish
centers within the selected municipalities were chosen for
data collection; the choice of these sites was based on
children’s distribution (13), comfort, privacy, and low
interference with the usual activities of the participants.
Within each selected kindergarten or parish center, all the
caregivers of children with 3–5 years of age were invited to
participate. A few additional children were recruited in the
selected municipalities outside of schools; this convenience
or accidental sample corresponds to <5% of the included
children.
Data collection
Data were collected using a structured questionnaire, admin-
istered by face-to-face interview to the caregivers. The field-
work was conducted between February and March 2007 by
trained interviewers.
Variables
The questionnaire used in this study was primarily adapted
from the Portuguese version of the ISAAC questionnaire (9)
for young children (6–7 years). It included questions on rhi-
nitis symptoms (repeated sneezing and/or itchy nose, blocked
and runny nose), severity, impact and treatment, as well as
physician-diagnosed rhinitis (PDR); data on current wheezing,
physician-diagnosed asthma, personal history of food or
drug allergy, family history of allergic disease (parents and
siblings), exposure to environmental tobacco smoke (ETS)
at home, area of residence (urban vs rural), and birthweight
were also collected. Tables S2 and S3 report the study’s
questionnaire and the questions’ sources.
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Definitions
The definitions used in this study are presented in Table 1.
Current rhinitis was classified, according to the ARIA
guidelines (4), in intermittent/persistent and mild/moderate–
severe rhinitis. This classification has been used in a birth
cohort at 13 years of age (14).
Bias
To avoid bias related to inadequate data collection, inter-
viewers had specific training in the study’s subject and in
data collection by face-to-face interview. The questionnaire
was kept simple and brief, which facilitated the inclusion of
participants and minimized the loss of ‘compliance’ through-
out the interview. The strict anonymity maintained through-
out study might have contributed to increased reliability of
the answers.
Statistical analysis
Categorical variables were described using absolute frequen-
cies and proportions with 95% confidence intervals (95%
CI); comparisons were performed with Pearson’s and linear-
by-linear association qui-square tests. Continuous variables
were described using mean with standard deviation (SD);
comparisons were performed with independent-samples t-test.
When necessary, continuous variables were categorized to
perform statistical analysis (e.g., birthweight). A P-value of
<0.05 was considered statistically significant.
Additionally, univariate and multiple logistic regression
analyses were performed; a description of these statistical
methods and the results obtained are available as supplemen-
tary material (‘Methods: Regression analysis’ and Table S6).
All the data analyses were performed using SPSS version
19.0 for Windows (IBM SPSS, Chicago, IL, USA).
Results
Participants
Overall, 5500 individuals were contacted and 5030 partici-
pated. Those without complete information regarding ‘cur-
rent rhinitis’ (n = 12) were excluded from the analysis
(Fig. 1). 90 children could not be classified according to
ARIA; information regarding missing data is available in
Fig. 1. The characteristics of 5018 included children are pre-
sented in Table 2.
Main results
‘Current rhinitis’ and ‘rhinoconjunctivitis’ using the ISAAC
definition
The prevalence of ‘current rhinitis’ using the ISAAC defini-
tion was 43.4% [95% CI (42.0–44.8%); n = 2179] (Table 3).
Of children with ‘current rhinitis’, 66.7% (n = 1453) reported
to have blocked nose, 47.7% (n = 1039) to have rhinorrhea,
and 45.8% (n = 997) sneezing/itchy nose; 13.2% (n = 287)
had all symptoms listed in the questionnaire. Symptoms of
conjunctivitis were reported by 759 (35.6%) of children with
‘current rhinitis’, accounting for a prevalence of rhinocon-
junctivitis of 15.3% [95% CI (14.3–16.3%)] (Table 3).
‘Current rhinitis’ severity and ARIA classification
In 66.5% of children with ‘current rhinitis’, symptoms
affected day-to-day routine over the last 12 months: ‘a little’
in 42.1%, ‘a moderate amount’ in 19.1%, and ‘a lot’ in
5.3%. Children with persistent rhinitis reported more interference
Table 1 Definitions of the variables included in the study. The study questionnaire and the sources of the questions are presented as
supplementary material
Variable Definition
Current rhinitis Presence in the last 12 months of sneezing and/or itchy nose, or a runny, or blocked nose without
having a cold or flu
Intermittent rhinitis Current rhinitis with nasal symptoms lasting <4 days in a week or lasting more than 4 days/week but
<4 consecutive weeks
Persistent rhinitis Current rhinitis with nasal symptoms lasting for at least 4 days in a week and for more than
4 consecutive weeks
Mild rhinitis Current rhinitis that is referred by the respondent to interfere ‘not at all’ or ‘a little’ in the child’s daily
activities, in the past 12 months (self-reported severity)
Moderate–severe rhinitis Current rhinitis that is referred by the respondent to interfere ‘a moderate amount’ or ‘a lot’ in
the child’s daily activities, in the past 12 months (self-reported severity)
Physician-diagnosed rhinitis Positive answer to the question ‘Has a doctor ever said the child has rhinitis?’
Rhinoconjunctivitis Presence of current rhinitis and a positive answer to the question: ‘In the past 12 months, has this
nose problem been usually accompanied by itchy-watery eyes?’
Current wheezing (CW) Positive answer to the question ‘Has the child had wheezing episodes over the last 12 months?’
Self-reported food allergy Positive answer to the question ‘Does the child have allergy to any foodstuff?’
Self-reported drug allergy Positive answer to the question ‘Does the child have allergy to any medication?’
Exposure to environmental
tobacco smoke (ETS)
at home
Exposure, at home, to at least one smoker (defined by a positive answer to the question ‘Does
anyone who lives with the child smoke at home?’)
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with daily routine than those with intermittent symptoms
(20.1 vs 2.9% with ‘a lot’ of interference, respectively,
P < 0.001). Considering the ARIA classification, 29.5%
[95% CI (28.5–30.8)] of the children had mild intermittent rhi-
nitis, 2.6% [95% CI (2.2–3.0)] mild persistent, 7.2% [95% CI
(6.5–7.9)] moderate–severe intermittent, and 3.2% [95% CI
(2.7–3.7)] moderate–severe persistent disease (Table 4).
‘Current rhinitis’ risk factors and comorbidities
Children living in a rural area had a significantly lower prev-
alence of ‘current rhinitis’. Children with ‘current rhinitis’
had more ‘current wheezing’, ‘physician-diagnosed asthma’,
‘self-reported food allergy’, and ‘family history of allergic dis-
ease’ than those without rhinitis. Similar results were found
in children with rhinoconjunctivitis (Table S4). In univariate
analysis, current wheezing presented the strongest association
with ‘current rhinitis’ {OR = 3.95 [95% CI (3.44–4.54)]} and
one of the strongest with rhinoconjunctivitis {OR = 3.50
[95% CI (2.98–4.11)]; Table S6}. In the multivariate analysis
including possible risk factors, family history of allergic
disease and living in an urban area were positively associ-
ated with both ‘current rhinitis’ and ‘rhinoconjunctivitis’
(Table S6).
Children with ‘current wheezing’ and those with family his-
tory of allergic disease, when compared to those without,
presented higher prevalence of all ARIA classes of rhinitis;
those with ‘physician-diagnosed asthma’, ‘self-reported food
allergy’, and ‘self-reported drug allergy’ had higher preva-
lence of more persistent and severe forms of the disease
(Table 4). Children living in an urban area had a higher
prevalence of intermittent rhinitis (39.0 vs 29.4% in those liv-
ing in rural areas, P < 0.001), and children with ETS expo-
sure at home had a lower prevalence of moderate–severe
rhinitis (8.1 vs 11.4% in those without ETS exposure,
P < 0.001; Table 4). A comparison between children without
rhinitis and those with different ARIA classes of rhinitis is
readily available in Table S5.
‘Physician-diagnosed rhinitis’: prevalence and risk factors
Physician-diagnosed rhinitis (PDR) was found in 11.7%
[95% CI (10.8–12.6%); n = 588] children. It was more fre-
quent in children with ‘current rhinitis’ (26.4 vs 0.5% in those
without rhinitis, P < 0.001), especially when associated with
nasal and ocular symptoms (44.4 vs 5.6% in those without
‘rhinoconjunctivitis’, P < 0.001; Table 3) and in moderate–
severe disease (51.0 vs 46.4% in mild rhinitis, P < 0.001;
5500 contacts
5030 participants
470 (9.1%) refused to participate
5018 included 
12 (0.2%) excluded from statistical analysis 
(insufficient information in most of the questionnaire)
4087 with complete information 931 (18.6%) with at least 1 missing information: 
- Family history of allergic disease*.. 394 (7.9%)
- Self-reported drug allergy………… 282 (5.6%)
- Self-reported food allergy………… 279 (5.6%)
- Birth weight………………………. 130 (2.6%)
- ARIA classification†……………... 90 (4.1%)
- Rhinoconjunctivitis……………….. 49 (1.0%)
- Rhinitis treatment…………………. 42 (0.8%)
- Physician-diagnosed asthma……… 40 (0.8%)
- Area of residence…………………. 29 (0.6%)
- Exposure to ETS at home…………. 24 (0.5%)
- Current wheezing…………………. 15 (0.3%)
- Physician-diagnosed rhinitis…….... 11 (0.2%)
*, 302 (6.0%) with missing information on the father, 202 (4.0%) on the mother and 107 (2.1%) on the 
siblings (1729 participants had no siblings); †, the presented percent considers children with “current 
rhinitis” 
Figure 1 Patient selection diagram and missing data regarding the study’s variables.
Allergy 68 (2013) 1278–1288 © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 1281
Morais-Almeida et al. Rhinitis in preschool children
Table 4). Risk factors and risk markers for PDR were similar
to those found for ‘current rhinitis’ and ‘rhinoconjunctivitis’
(Tables 3 and Table S6).
Rhinitis underdiagnosis
Seventy-four percent (n = 1601) of children with ‘current
rhinitis’ had no previous PDR (Table 5). Children with un-
derdiagnosed disease presented milder rhinitis (85.4% of chil-
dren without PDR had mild disease vs 47.6% of those
previously diagnosed, P < 0.001) and more intermittent
symptoms (89.9 vs 77.3%, respectively, P < 0.001). Children
with ‘current rhinitis’ without PDR had less ‘current wheez-
ing’, ‘physician-diagnosed asthma’, self-reported food and
drug allergy, and less maternal and sibling’s history of aller-
gic disease (Table 5).
Rhinitis treatment
Twenty-six percent (n = 563) of the children with ‘current
rhinitis’ received rhinitis treatment (topical or oral) in the
previous year. It was more frequently used in children with
moderate–severe rhinitis (56.4 vs 16.3% in mild rhinitis,
P < 0.001), in those with PDR (92.8 vs 0.9% in those with-
out, P < 0.001), and those with ‘rhinoconjunctivitis’ (44.5 vs
5.5% in those without current nasal and ocular symptoms,
P < 0.001) (Tables S4 and S5).
Discussion
Key results
Over 40% of Portuguese preschool children had ‘current rhi-
nitis’ as defined by ISAAC. Only 11.7% had physician-diag-
nosed rhinitis (PDR). As defined by ARIA, two-thirds of the
children with ‘current rhinitis’ had mild intermittent disease,
17% moderate–severe intermittent, over 7% moderate–severe
persistent, and around 6% mild persistent rhinitis. Children
with ‘current rhinitis’, PDR, and/or rhinoconjunctivitis, when
compared to those without, had more ‘current wheezing’,
‘physician-diagnosed asthma’, ‘self-reported food allergy’,
and ‘family history of allergic disease’. These characteristics
were also associated with rhinitis persistency and higher
severity.
Strengths and limitations
This is the first truly nationwide study assessing rhinitis
prevalence in preschool children, although population-based
studies have been carried out in Sweden (15), Italy (6), and
Colombia (7) and some data exist from birth cohorts (5, 16).
Moreover, this is the first population-based nationwide study
in this age-group reporting rhinitis classification according to
ARIA.
The major limitations of this study are the lack of physi-
cian diagnosis confirmation and allergy assessment. More-
over, this study lacks information on the frequency of
rhinitis episodes over the past year; however, by focusing on
‘current rhinitis’ and on the presence of rhinitis symptoms
regardless of their frequency, the possibility of recall bias due
to retrospective data collection was minimized.
We used a rhinitis definition similar to ISAAC. However,
in our study, the presence of blocked nose, sneezing, and
rhinorrhea was independently asked, while in ISAAC, a sin-
gle question globally assessed the same symptoms (9); it is
unknown whether the use of these two different ways to per-
form the same question may have elicited divergent
responses. Moreover, questionnaire-based definition of rhinitis,
without clinical correlation, may lead to misclassification of
the studies’ participants (17). Furthermore, the ISAAC rhini-
tis-specific questions were originally validated in children by
comparison with aeroallergen sensitization (18), which is
arguable. To our knowledge, only a recent study reported a
validation of ISAAC questions (regarding rhinitis symptoms
and rhinoconjunctivitis) against physician-diagnosed allergic
rhinitis (17), and they were associated with only moderate
accuracy. Considering ARIA (4), which recommends the use
of atopy objective markers to define allergic rhinitis (AR),
and the limitations of the ISAAC questions in defining AR,
in our study, only ‘rhinitis’, without specification as allergic
or nonallergic, was reported. As the cause of rhinitis in pre-
school children is still poorly understood, it seems appropri-
ate to include an in vivo or in vitro IgE-sensitization marker
in future studies.
Interpretation and generalizability
Rhinitis prevalence was higher than those found for pre-
school children in cities of Italy (16.8%) (6), Sweden [5.7%
in Varmland (15), 10.8% in Stockholm (16)], the United
Kingdom (26.1%) (5), and Colombia (30.4%) (7). This vari-
ability may be related to regional differences, age-groups
studied [children younger than 3 years of age were included
Table 2 Characteristics of the participants (n = 5018)
N (%*)
Male gender 2561 (51.0)
Age (years)
3 1678 (33.4)
4 1669 (33.3)
5 1671 (33.3)
Birthweight (kg)
<2.50 633 (13.0)
≥2.50 until 3.99 3923 (80.3)
≥4.00 330 (6.8)
Living in a urban area 3792 (76.0)
Current wheezing 1228 (24.5)
Physician-diagnosed asthma, ever 228 (4.6)
Self-reported food allergy 316 (6.7)
Self-reported drug allergy 129 (2.7)
Family history of allergic disease, present 1419 (30.7)
Father 567 (12.0)
Mother 830 (17.2)
Sibling 326 (10.2)
Exposed to ETS at home 1528 (30.6)
ETS, environmental tobacco smoke exposure.
*Valid percents.
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Table 3 Prevalence of current rhinitis (n = 5018), physician-diagnosed rhinitis (n = 5007), and rhinoconjunctivitis (n = 4969) according to
demographic characteristics and disease status
‘Current rhinitis’ ‘Physician-diagnosed rhinitis’ ‘Rhinoconjunctivitis’
n (%) [95% CI] n (%) [95% CI] n (%) [95% CI]
All 2179 (43.4) [42.0–44.8] 588 (11.7) [10.8–12.6] 759 (15.3) [14.3–16.3]
Gender 0.281* 0.304* 0.035*
Male 1131 (44.2) [42.3–46.1] 312 (12.2) [10.9–13.5] 414 (16.3) [14.9–17.7]
Female 1048 (42.7) [40.7–44.7] 276 (11.3) [10.0–12.6] 345 (14.2) [12.8–15.6]
Age (years) 0.361* 0.998* 0.557*
3 740 (44.1) [41.7–46.5] 196 (11.7) [10.2–13.2] 258 (15.5) [13.8–17.2]
4 737 (44.2) [41.8–46.6] 196 (11.8) [10.3–13.3] 261 (15.8) [14.0–17.6]
5 702 (42.0) [39.6–44.4] 196 (11.8) [10.3–13.3] 240 (14.5) [12.8–16.2]
Birthweight (kg) 0.002* 0.001* 0.062*
<2.50 307 (48.5) [44.6–52.4] 98 (15.6) [12.8–18.4] 105 (16.9) [14.0–19.8]
≥2.50 until 3.99 1705 (43.5) [41.9–45.1] 429 (10.9) [9.9–11.9] 604 (15.5) [14.4–16.6]
≥4.00 121 (36.7) [31.5–41.9] 47 (14.2) [10.4–18.0] 36 (11.1) [7.7–14.5]
Area of residence <0.001* <0.001* 0.002*
Urban 1739 (45.9) [44.3–47.5] 486 (12.8) [11.7–13.9] 606 (16.1) [14.9–17.3]
Rural 427 (35.7) [33.0–38.4] 101 (8.4) [6.8–10.0] 147 (12.5) [10.6–14.4]
Current rhinitis NA <0.001*
Without current rhinitis 15 (0.5) [0.2–0.8] NA
With current rhinitis 573 (26.4) [24.5–28.3] 759 (35.6) [33.6–37.6]
Physician-diagnosed rhinitis (PDR) <0.001* NA <0.001*
Without PDR 1601 (36.2) [34.8–37.6] 421 (9.6) [8.7–10.5]
With PDR 573 (97.4) [96.1–98.7] 336 (58.8) [54.8–62.8]
Rhinoconjunctivitis NA <0.001* NA
Without rhinoconjunctivitis 235 (5.6) [4.9–6.3]
With rhinoconjunctivitis 336 (44.4) [40.9–47.9]
Rhinitis treatment <0.001* <0.001* <0.001*
Without rhinitis treatment 1592 (36.2) [34.8–37.6] 42 (1.0) [0.7–1.3] 417 (9.6) [8.7–10.5]
With rhinitis treatment 563 (96.7) [95.2–98.2] 544 (93.5) [91.5–95.5] 335 (59.2) [55.2–63.2]
Current wheezing <0.001* <0.001* <0.001*
Without current wheezing 1336 (35.4) [33.9–36.9] 323 (8.6) [7.7–9.5] 401 (10.7) [9.7–11.7]
With current wheezing 840 (68.4) [65.8–71.0] 265 (21.7) [19.4–24.0] 358 (29.6) [27.0–32.2]
Physician-diagnosed asthma
(PDA), ever
<0.001* <0.001* <0.001*
Without PDA 1997 (42.0) [40.6–43.4] 510 (10.8) [9.9–11.7] 652 (13.9) [12.9–14.8]
With PDA 167 (73.2) [67.5–78.9] 76 (33.5) [27.4–39.6] 100 (44.8) [38.3–51.3]
Self-reported food allergy 0.003* 0.001* <0.001*
Without food allergy 1946 (44.0) [42.5–45.5] 522 (11.8) [10.8–12.8] 663 (15.1) [14.0–16.2]
With food allergy 166 (52.5) [47.0–58.0] 58 (18.4) [14.1–22.7] 84 (26.8) [21.9–31.7]
Self-reported drug allergy 0.650* 0.077* 0.001*
Without drug allergy 2050 (44.5) [43.1–45.9] 557 (12.1) [11.1–13.0] 712 (15.6) [14.5–16.7]
With drug allergy 60 (46.5) [37.9–55.1] 22 (17.3) [10.8–23.8] 34 (26.6) [18.9–34.3]
Family history of allergic disease <0.001* <0.001* <0.001*
Without family history 1267 (39.5) [37.8–41.2] 296 (9.3) [8.3–10.3] 370 (11.7) [10.6–12.8]
With family history 752 (53.0) [50.4–55.6] 250 (17.7) [15.7–19.7] 315 (22.4) [20.2–24.6]
Father 308 (54.3) [50.2–58.4] 92 (16.3) [13.3–19.3] 138 (24.4) [20.9–27.9]
Mother 451 (54.3) [50.9–57.7] 161 (19.4) [16.7–22.1] 186 (22.7) [19.8–25.6]
Sibling 159 (48.8) [43.4–54.2] 63 (19.3) [15.0–23.6] 72 (22.3) [17.8–26.8]
Exposure to ETS at home 0.831* 0.341* 0.370*
Not exposed to ETS 1504 (43.4) [41.8–45.0] 418 (12.1) [11.0–13.2] 537 (15.6) [14.4–16.8]
Exposed to ETS 668 (43.7) [41.2–46.2] 170 (11.1) [9.5–12.7] 221 (14.6) [12.8–16.4]
ETS, environmental tobacco smoke.
*P-value for difference between prevalence (considering different categories of each characteristic/disease status).
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in Varmland – Sweden (15) and Colombia (7)], selection
methodology [the Manchester study (5) and the BAMSE
study (16) were retrieved from birth cohorts, the Dampness
in Building and Health Study (15) was based on a population
cohort, while the others were cross-sectional population-
based studies], and definition used. This prevalence is also
higher than those of current rhinitis in children aged 6 to
7 years (23.4% in Portugal and 21.4% worldwide) and
13–14 years (26.5% in Portugal and 31.7% worldwide)
reported in ISAAC (19).
We found that the most common nasal symptom was
blocked nose, which differs from studies in allergic rhinitis in
adults (20). This may be due to the inclusion of children with
both allergic and nonallergic rhinitis or to other differential
diagnosis that are highly prevalent in preschool children
(e.g., adenoidal hypertrophy). These findings suggest thatT
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Table 5 Characteristics of children with ‘current rhinitis’ according
to the presence or absence of a rhinitis medical diagnosis
Children with current rhinitis—ISAAC
(n = 2179)
With
physician-
diagnosed
rhinitis
[n = 573
(26.4%)]
Without
physician-
diagnosed
rhinitis
[n = 1601
(73.6%)]
P-valuen (%) n (%)
Gender, male 306 (53.4) 822 (51.3) 0.397
Age (years) 0.792
3 192 (33.5) 546 (34.1)
4 190 (33.2) 546 (34.1)
5 191 (33.3) 509 (31.8)
Birthweight (kg) 0.001
<2.50 98 (17.5) 207 (13.2)
≥2.50 until 3.99 419 (74.7) 1283 (81.9)
≥4.00 44 (7.8) 77 (4.9)
Living in an urban
area
477 (83.4) 1257 (79.1) 0.027
Rhinoconjunctivitis 336 (60.4) 421 (26.8) <0.001
Rhinitis treatment 531 (93.0) 32 (2.0) <0.001
Current wheezing 263 (45.9) 574 (35.9) <0.001
Physician-diagnosed
asthma, ever
76 (13.3) 91 (5.7) <0.001
Self-reported food
allergy
58 (10.2) 108 (7.0) 0.014
Self-reported drug
allergy
22 (3.9) 37 (2.4) 0.065
Family history of
allergic disease
242 (45.6) 508 (34.3) <0.001
Father 87 (16.3) 220 (14.5) 0.321
Mother 156 (28.1) 294 (19.0) <0.001
Sibling 60 (16.9) 99 (10.0) 0.001
Exposed to ETS
at home
163 (28.4) 504 (31.6) 0.158
ETS, environmental tobacco smoke exposure.
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ISAAC definition is particularly unspecific in this age-group
and that it could be improved. However, the use of an alter-
native definition (e.g., combination of symptoms) would limit
comparability with other reports and would need validation
as an epidemiological tool for assessing rhinitis in children.
Few studies have used the ARIA classification in pre-
schoolers, and none included children irrespective of their
atopy status. Hamouda et al. (21), when classifying allergic
rhinitis in preschool children with current asthma, found a
higher prevalence of mild persistent rhinitis (25%) and less
moderate–severe disease (2%). Keil et al. (14) presented data
from a birth cohort of children with high risk of allergy; they
found that 41% of children with allergic rhinitis defined by
ISAAC criteria presented mild persistent and 27% moderate–
severe persistent rhinitis. We also found that as reported for
adults (20) and school-aged children (22), persistent forms of
rhinitis were associated with increased perceived severity. To
our knowledge, the ARIA classification is not validated for
use in preschoolers; however, both the original classification
(23) and a modified version (22), which considers moderate
rhinitis separately from severe rhinitis, were recently vali-
dated for use in school-aged children. Moreover, it was never
used to classify nonallergic rhinitis in children, although in
adults, it was regarded as a useful pragmatic approach (11).
In fact, nonallergic rhinitis is frequent in the general popula-
tion and has no widely accepted classification system (11);
the use of a single classification would allow a better compa-
rability between clinical characteristics of allergic and nonal-
lergic rhinitis and would provide a useful tool when atopy
status is unknown, as in our study. However, this approach
in children still needs validation.
In this study, rhinoconjunctivitis had a similar prevalence
to that found by Marinho et al. (5) in preschool children and
to the overall global prevalence (15%) reported by ISAAC in
13- to 14 year-old children (19). The presence of rhinocon-
junctivitis (vs rhinitis alone) has been regarded as a more
probable allergic condition and has been suggested as a use-
ful surrogate marker for ‘allergic rhinitis’ in epidemiological
studies (24). In our report, around one-third of children with
current rhinitis presented rhinoconjunctivitis, suggesting that
atopy explains only part of current rhinitis symptoms in pre-
schoolers.
Of children with current rhinitis, PDR was referred in
26.4% and rhinitis treatment was used in 26.1%. Underdiag-
nosis and lack of treatment could be related to the under-
valuation of rhinitis symptoms by both caregivers and
physicians, despite the known impact in the child’s quality of
life (25).
In our study, preschool children with current wheezing,
physician-diagnosed asthma, self-reported food allergy, and
family history of allergic disease presented significantly higher
prevalence of current rhinitis, as previously found (1, 5, 6,
16, 26). We also report an association between these charac-
teristics and rhinitis severity, which supports that there is a
strong link between allergic disorders even at preschool age.
When examining environmental factors, we found that
children living in a rural area had lower current rhinitis
prevalence. This is not a consensual finding, and both studies
reporting similar (27) and opposite (28) results have been
published. The exposure to higher levels of outdoor pollu-
tants in urban areas, which were associated with increased
nasal symptoms and allergic rhinitis (29, 30), may partially
explain our findings.
Most studies do not show a clear association between ETS
exposure and rhinitis (31, 32), although some suggest that
ETS is associated with more persistent nasal symptoms (33).
In this study, no association was found between ETS expo-
sure at home and current rhinitis, but an inverse association
was found with moderate–severe persistent rhinitis. We
hypothesize that this finding may be due to a reverse causa-
lity phenomenon or a reporting bias in which caregivers of
children with more severe and persistent nasal symptoms are
more prone to cease smoking or to under-report smoking
habits, respectively.
Conclusions
This was the first population-based nationwide study report-
ing rhinitis classification according to ARIA in preschool
children. More than 40% of Portuguese preschoolers had
current rhinitis, of which about 25% had moderate–severe
disease. Current wheezing, physician-diagnosed asthma, self-
reported food allergy, and family history of allergic disease
were associated with current rhinitis, namely with persistent
and moderate–severe forms.
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